Mario Raviglione

Mario Raviglione

Università degli Studi di Milano

H-index: 118

Europe-Italy

About Mario Raviglione

Mario Raviglione, With an exceptional h-index of 118 and a recent h-index of 60 (since 2020), a distinguished researcher at Università degli Studi di Milano, specializes in the field of global health, tuberculosis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis

Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation

Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

‘One Health´ approach to end zoonotic TB

Drug resistant tuberculosis in Italy through a global health lens

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

High variability in tuberculosis treatment outcomes across 15 health facilities in a semi-urban area in central Ethiopia

Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low‐and middle‐income countries

Mario Raviglione Information

University

Position

Professor of Global Health Italy

Citations(all)

64191

Citations(since 2020)

16411

Cited By

63570

hIndex(all)

118

hIndex(since 2020)

60

i10Index(all)

305

i10Index(since 2020)

184

Email

University Profile Page

Università degli Studi di Milano

Google Scholar

View Google Scholar Profile

Mario Raviglione Skills & Research Interests

global health

tuberculosis

Top articles of Mario Raviglione

Title

Journal

Author(s)

Publication Date

Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis

BMJ Global Health

Simone Villa

Pierpaolo de Colombani

Lucia Dall’Olio

Giuliano Gargioni

Mario Raviglione

2024/4/1

Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation

BMJ Global Health

Astrid Berner-Rodoreda

Frank Cobelens

Anne-Mieke Vandamme

Günter Froeschl

Jolene Skordis

...

2024/2/1

Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

Franz Koenig

Cécile Spiertz

Daniel Millar

Sarai Rodríguez-Navarro

Núria Machín

...

2024/1/1

‘One Health´ approach to end zoonotic TB

S Villa

M Carugati

MP Rubach

Sarah Cleaveland

SG Mpagama

...

2023/2/1

Drug resistant tuberculosis in Italy through a global health lens

Federico Fama

Camilla Genovese

Mario Raviglione

Andrea Gori

2023/5/1

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

Michael Reid

Yvan Jean Patrick Agbassi

Nimalan Arinaminpathy

Alyssa Bercasio

Anurag Bhargava

...

2023/9/13

High variability in tuberculosis treatment outcomes across 15 health facilities in a semi-urban area in central Ethiopia

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Giuseppe Zenatti

Mario Raviglione

Fregenet Tesfaye

Kidist Bobosha

Per Björkman

...

2023/2/1

Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low‐and middle‐income countries

Journal of Medical Virology

Elisabetta Tanzi

Silvia Bianchi

Clara Fappani

Maria Gori

Daniela Colzani

...

2023/5

Global Health Essentials

Mario CB Raviglione

Fabrizio Tediosi

Simone Villa

Núria Casamitjana

Antoni Plasència

2023/9/7

Tuberculosis: current challenges and beyond

Breathe

Raquel Villar-Hernández

Arash Ghodousi

Olha Konstantynovska

Raquel Duarte

Christoph Lange

...

2023/3/1

The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

Frontiers in Medicine

Marta Canuti

Maria Cristina Monti

Chiara Bobbio

Antonio Muscatello

Toussaint Muheberimana

...

2023/9/7

Reducing the burden of TB among migrants to low TB incidence countries

I Spruijt

C Erkens

C Greenaway

C Mulder

M Raviglione

...

2023/3/1

First report of Colias croceus ab. cremonae in Italy: (Lepidoptera Pieridae)

Bollettino della Società Entomologica Italiana

Mario Carlo Battista Raviglione

Fabrizio Boggio

Marco Raviglione

Alberto Zilli

2023/8/30

Tuberculosis, Epidemiology of

Giovanni Sotgiu

Matteo Zignol

Mario C Raviglione

2023/2/8

Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017–2022

Virology Journal

Silvia Bianchi

Clara Fappani

Maria Gori

Marta Canuti

Daniela Colzani

...

2023/7/20

Ending TB in South-East Asia: flagship priority and response transformation

Vineet Bhatia

Suman Rijal

Mukta Sharma

Akramul Islam

Anna Vassall

...

2023/11/1

Global ecological analysis of COVID-19 mortality and comparison between “the East” and “the West”

Scientific Reports

Ariel Pablos-Méndez

Simone Villa

Maria Cristina Monti

Mario Carlo Raviglione

Hilary Brown Tabish

...

2022/3/28

Agrofood system and human health

Stefano Bocchi

Simone Villa

Francesca Orlando

Ludovico Grimoldi

Mario Raviglione

2022/3/3

Pandemic Preparedness and Response: The WHO's Role in the'New Normal'

Global Asia

Simone Villa

Giorgia Renne

Ariel Pablos-Méndez

Mario C Raviglione

2022/3

Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy

Environmental Research

Antonella Amendola

Marta Canuti

Silvia Bianchi

Sudhir Kumar

Clara Fappani

...

2022/12/1

See List of Professors in Mario Raviglione University(Università degli Studi di Milano)